NCT04142372Active, not recruiting
Tissue Microarray of Hematological Malignancies
Tissue Microarray of Hematological Malignancies: Search for Novel Regulators of Disease Pathology Across Disease Entities
Source: ClinicalTrials.gov · Last updated 24 Apr 2024
Brief summary (registry, in English)
The aim of the study is to create new tools for improving management of patients with hematological malignancies by combining extensive clinical data from patients newly diagnosed with hematological malignancies and innovative laboratory analyses made on available tissue samples in regional biobanks from these patients.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 5000 (estimated)
- First submitted
- 18 Sept 2019
- Start date
- 10 Mar 2020
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Tampere University Hospital
- Diseases
- Myeloproliferative neoplasms, Myelodysplastic syndromes, Multiple myeloma, Childhood cancers
- NCT number
- NCT04142372
What you commit to
- Study type: Observational
- Planned participants: 5000
- From 10 Mar 2020 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Non-sufficient data available
Who the study is looking for
- hematological malignancy/neoplasm
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Tampere Univerisity Hospital Coordinator of this site? Confirm its status | Tampere | Finland | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.